Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) declared a dividend on Wednesday, November 26th, investing.com reports. Shareholders of record on Monday, December 1st will be paid a dividend of 0.03 per share on Monday, December 15th. This represents a yield of 244.0%. The ex-dividend date of this dividend is Friday, November 28th.
Extendicare Stock Up 0.7%
OTCMKTS EXETF traded up $0.11 during trading on Wednesday, hitting $14.82. The company had a trading volume of 1,796 shares, compared to its average volume of 13,772. The company’s fifty day moving average is $12.05 and its 200-day moving average is $10.63. Extendicare has a one year low of $6.72 and a one year high of $14.83.
Wall Street Analysts Forecast Growth
Several analysts have commented on EXETF shares. TD Securities restated a “hold” rating on shares of Extendicare in a report on Friday, November 14th. CIBC assumed coverage on Extendicare in a research report on Monday, September 22nd. They set an “outperform” rating on the stock. Finally, BMO Capital Markets restated a “market perform” rating on shares of Extendicare in a report on Monday, August 11th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Extendicare presently has an average rating of “Hold”.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
See Also
- Five stocks we like better than Extendicare
- How to Short a Stock in 5 Easy StepsĀ
- These 2 Energy Titans Just Scored Major Wins to Close Out November
- How to Calculate Options Profits
- Analog Devices Moves Higher as Super-Cycle Gains Momentum
- 3 Stocks to Consider Buying in October
- Microsoft Stock Faces An AI-Driven Physics Problem
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
